Panacea Life Sciences Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-06-30 was 1.00M shares.
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-03-31 was 0.00 shares.
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2018 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2021-06-30 | 1.00M shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2021-08-23 | |
| 2021-03-31 | 0.00 shares 10-Q/A · filed 2021-05-27 | |
| 2018-12-31 | 0.00 shares 10-K · filed 2019-03-29 |